Denufosol Tetrasodium

地纽福索四钠

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameDenufosol Tetrasodium
Drug Alias Name地纽福索INS-37217INS 37217 ophthalmicINS37217 Respiratory
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y2 agonists
TargetsPurinergic receptor P2Y2
Therapy Area/IndicationsUveitisRetinal DetachmentMacular Edema +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNew Zealand +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsUveitisRetinal DetachmentMacular Edema +[5] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG